SMARCA2 and neoplasm: Based on our analysis of the single‐cell dataset, we observed a significant decrease in the expression of SMARCA2 in tumor cells, particularly in anaplastic thyroid cancer (ATC) cells, compared to that in normal thyroid follicular epithelial cells (Figure 6H,I).